111 related articles for article (PubMed ID: 20970300)
1. Study on anti-metastasis of heparin derivatives as ligand antagonist of p-selectin.
Li Y; Luo JY; Cui HF; Zheng L; Du SS
Biomed Pharmacother; 2010 Dec; 64(10):654-8. PubMed ID: 20970300
[TBL] [Abstract][Full Text] [Related]
2. Selectively desulfated heparin inhibits P-selectin-mediated adhesion of human melanoma cells.
Wei M; Gao Y; Tian M; Li N; Hao S; Zeng X
Cancer Lett; 2005 Nov; 229(1):123-6. PubMed ID: 16157224
[TBL] [Abstract][Full Text] [Related]
3. Melanoma cell adhesion can be blocked by heparin in vitro: suggestion of VLA-4 as a novel target for antimetastatic approaches.
Fritzsche J; Simonis D; Bendas G
Thromb Haemost; 2008 Dec; 100(6):1166-75. PubMed ID: 19132244
[TBL] [Abstract][Full Text] [Related]
4. Antitumor properties of a new non-anticoagulant heparin analog from the mollusk Nodipecten nodosus: Effect on P-selectin, heparanase, metastasis and cellular recruitment.
Gomes AM; Kozlowski EO; Borsig L; Teixeira FC; Vlodavsky I; Pavão MS
Glycobiology; 2015 Apr; 25(4):386-93. PubMed ID: 25367817
[TBL] [Abstract][Full Text] [Related]
5. O-sulfated bacterial polysaccharides with low anticoagulant activity inhibit metastasis.
Borgenström M; Wärri A; Hiilesvuo K; Käkönen R; Käkönen S; Nissinen L; Pihlavisto M; Marjamäki A; Vlodavsky I; Naggi A; Torri G; Casu B; Veromaa T; Salmivirta M; Elenius K
Semin Thromb Hemost; 2007 Jul; 33(5):547-56. PubMed ID: 17629853
[TBL] [Abstract][Full Text] [Related]
6. Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions.
Wei M; Tai G; Gao Y; Li N; Huang B; Zhou Y; Hao S; Zeng X
J Biol Chem; 2004 Jul; 279(28):29202-10. PubMed ID: 15133030
[TBL] [Abstract][Full Text] [Related]
7. Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects.
Stevenson JL; Varki A; Borsig L
Thromb Res; 2007; 120 Suppl 2():S107-11. PubMed ID: 18023703
[TBL] [Abstract][Full Text] [Related]
8. Antimetastatic activities of modified heparins: selectin inhibition by heparin attenuates metastasis.
Borsig L
Semin Thromb Hemost; 2007 Jul; 33(5):540-6. PubMed ID: 17629852
[TBL] [Abstract][Full Text] [Related]
9. P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins.
Hostettler N; Naggi A; Torri G; Ishai-Michaeli R; Casu B; Vlodavsky I; Borsig L
FASEB J; 2007 Nov; 21(13):3562-72. PubMed ID: 17557930
[TBL] [Abstract][Full Text] [Related]
10. Chemically modified heparin inhibits the in vitro adhesion of nonsmall cell lung cancer cells to P-selectin.
Gao Y; Wei M; Zheng S; Ba X; Hao S; Zeng X
J Cancer Res Clin Oncol; 2006 Apr; 132(4):257-64. PubMed ID: 16331491
[TBL] [Abstract][Full Text] [Related]
11. Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.
Rao NV; Argyle B; Xu X; Reynolds PR; Walenga JM; Prechel M; Prestwich GD; MacArthur RB; Walters BB; Hoidal JR; Kennedy TP
Am J Physiol Cell Physiol; 2010 Jul; 299(1):C97-110. PubMed ID: 20375277
[TBL] [Abstract][Full Text] [Related]
12. The attenuation of experimental lung metastasis by a bile acid acylated-heparin derivative.
Park K; Ki Lee S; Hyun Son D; Ah Park S; Kim K; Won Chang H; Jeong EJ; Park RW; Kim IS; Chan Kwon I; Byun Y; Kim SY
Biomaterials; 2007 Jun; 28(16):2667-76. PubMed ID: 17335894
[TBL] [Abstract][Full Text] [Related]
13. The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo.
Ludwig RJ; Alban S; Bistrian R; Boehncke WH; Kaufmann R; Henschler R; Gille J
Thromb Haemost; 2006 Mar; 95(3):535-40. PubMed ID: 16525583
[TBL] [Abstract][Full Text] [Related]
14. Kinetic analysis of heparin and glucan sulfates binding to P-selectin and its impact on the general understanding of selectin inhibition.
Simonis D; Fritzsche J; Alban S; Bendas G
Biochemistry; 2007 May; 46(20):6156-64. PubMed ID: 17458940
[TBL] [Abstract][Full Text] [Related]
15. [The effect of intraperitoneal heparin on distribution of ACC-M in lung and liver].
Wang XJ; Chen WT; Zhou ZY; Ma YQ; Zhou XJ
Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Jun; 22(3):246-7. PubMed ID: 15293477
[TBL] [Abstract][Full Text] [Related]
16. Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase.
Sun ZJ; Chen G; Zhang W; Hu X; Huang CF; Wang YF; Jia J; Zhao YF
J Pharmacol Exp Ther; 2010 Aug; 334(2):500-12. PubMed ID: 20484154
[TBL] [Abstract][Full Text] [Related]
17. The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacity.
Fritzsche J; Alban S; Ludwig RJ; Rubant S; Boehncke WH; Schumacher G; Bendas G
Biochem Pharmacol; 2006 Aug; 72(4):474-85. PubMed ID: 16780802
[TBL] [Abstract][Full Text] [Related]
18. Antimetastatic effect of an orally active heparin derivative on experimentally induced metastasis.
Lee DY; Park K; Kim SK; Park RW; Kwon IC; Kim SY; Byun Y
Clin Cancer Res; 2008 May; 14(9):2841-9. PubMed ID: 18451252
[TBL] [Abstract][Full Text] [Related]
19. Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans.
Varki NM; Varki A
Semin Thromb Hemost; 2002 Feb; 28(1):53-66. PubMed ID: 11885026
[TBL] [Abstract][Full Text] [Related]
20. Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins.
Wang L; Brown JR; Varki A; Esko JD
J Clin Invest; 2002 Jul; 110(1):127-36. PubMed ID: 12093896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
